ORAMED PHARMACEUTICALS INC. 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Zommer Yifat Hen
CFO, Treasurer and Secretary
Transactions
- Award
Stock Option (right to buy)
[F1]2017-06-30+20,001→ 20,001 totalExercise: $7.77Exp: 2027-06-30→ Common Stock (20,001 underlying)
Footnotes (1)
- [F1]The Stock Option will vest in 3 equal installments of 6,667 on each of December 31, 2017, December 31, 2018 and December 31, 2019.
Signature
/s/ Yifat Zommer|2017-07-05